|
1022
|
N 0425 hydrochloride
|
MAO inhibitor |
€95.00 |
|
1062
|
N 0425 hydrochloride, (+)-
|
MAO inhibitor |
€135.00 |
|
1063
|
N 0425 hydrochloride, (-)-
|
MAO inhibitor |
€135.00 |
|
1065
|
N 0426 hydrochloride
|
Dopamine agonist |
Inquire |
|
1018
|
N 0430 hydrobromide
|
MAO inhibitor; Dopamine agonist |
€115.00 |
|
1020
|
N 0432 hydrobromide
|
MAO inhibitor; Dopamine agonist |
Inquire |
|
1038
|
N 0437 hydrochloride
|
Dopamine agonist |
€135.00 |
|
1041
|
N 0734 hydrochloride
|
Dopamine agonist |
€115.00 |
|
1039
|
N 0924 hydrochloride
|
Dopamine agonist; less active enantiomer of N-0437 (Axon 1038) |
Inquire |
|
1249
|
N 20C hydrochloride
|
NMDA antagonist |
€85.00 |
|
1061
|
N,N-dibutyldopamine hydrobromide
|
Dopamine agonist |
€95.00 |
|
1001
|
N,N-Dipropyldopamine hydrobromide
|
Dopamine agonist |
€95.00 |
|
1067
|
N-Cyclopropyl-2-Aminotetraline hydrochloride
|
MAO inhibitor |
Inquire |
|
2833
|
N-Desmethyl-PK 11195
|
Radioligand precursor of the benzodiazepine antagonist PK 11195 |
€105.00 |
|
2846
|
N-Desmethylclozapine
|
Metabolite of Clozapine |
€90.00 |
|
1023
|
N-Methyl-N-n-propyl-2-aminotetraline hydrochloride
|
Dopamine agonist |
Inquire |
|
2565
|
N106
|
Activator of E1 ligase mediated SERCA2a SUMOylation |
€95.00 |
|
1822
|
N6022
|
Inhibitor of S-nitrosoglutathione reductase (GSNOR) |
€90.00 |
|
3656
|
Naftifine hydrochloride
|
Topical broad-spectrum antifungal agent |
€50.00 |
|
5011
|
Naive Stem Cell 5i inhibitor Set
|
Set of five inhibitors for the induction and maintenance of human naive stem cell pluripotency |
€200.00 |
|
5010
|
Naive Stem Cell NHSM inhibitor Set
|
Set of inhibitors for isolation, generation, derivatization and stabilization of naive hPSCs |
€230.00 |
|
1577
|
Nalbuphine hydrochloride
|
Analgesic. Κ-opioid agonist and μ-opioid antagonist/partial agonist |
€140.00 |
|
1573
|
Nalmefene hydrochloride
|
Opioid antagonist |
€90.00 |
|
1205
|
Naloxonazine dihydrochloride
|
Opioid antagonist |
€85.00 |
|
1230
|
Naloxone Benzoylhydrazone
|
Kappa-opioid agonist |
€85.00 |
|
2415
|
Naloxone hydrochloride
|
Neutral opioid antagonist |
€50.00 |
|
2416
|
Naltrexone hydrochloride
|
Competitive opioid antagonist with preference for µ- and κ-receptors |
€45.00 |
|
2517
|
Napabucasin
|
Oral first-in-class cancer stemness inhibitor that works by targeting STAT3 |
€105.00 |
|
3364
|
Naproxen sodium
|
COX-inhibitor; NSAID |
€40.00 |
|
3493
|
Natamycin
|
Antifungal agent |
€60.00 |